India’s Foremost Trade & Investment Magazine
Indian drug firm Wockhardt has received approval from the US health regulator to market its Oxycodone HCl liquid, used for treating chronic pain, in the American market.
Sign-up for full access to India Global Business. It's FREE
Already a subscriber? Log in